TFS International AB:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:TFS International AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10579
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
TFS International AB (TFS International) is a contract research organization that provides clinical development solutions. The organization through its business areas, TFS Develop and TFS People, provides various services worldwide including clinical development planning, regulatory affairs, feasibility, study and site coordination, among others. It offers patient recruitment services, clinical data management, biostatistics, pharmacovigilance and safety, medical writing, training, quality assurance and functional service solutions, among others. TFS International offers therapeutic areas such as oncology, cardiovascular, dermatology, immunology, CNS, endocrinology and ophthalmology, among others. The organization offers scientific advice, product development consulting, protocol design, and other services. It operates through regional and sales offices in Sweden and the US. TFS International is headquartered in Lund, Sweden

TFS International AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
TFS International AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TFS International AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TFS International AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TFS International AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
TFS International AB, Medical Devices Deals, 2012 to YTD 2018 9
TFS International AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
TFS International AB, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
TFS Trial Form Support International Completes Acquisition Of Contract Research Business Of Semcon Caran 11
Private Equity 13
Ratos to Acquire 60% Stake in TFS International 13
Partnerships 14
Araclon Biotech Enters into Agreement with TFS International 14
TiGenix Forms Partnership with TFS International 15
TFS Enters into Agreement with SCIderm for Dermatology Trials 16
Acquisition 17
TFS International Acquires SCIderm 17
TFS Trial Form Support International Acquires Beardsworth Consulting, Contract Research Organization 18
TFS Trial Form Support International Acquires Dimensione Ricerca, Clinical CRO 19
TFS International AB – Key Competitors 20
TFS International AB – Key Employees 21
TFS International AB – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 24
Corporate Communications 24
Jun 20, 2018: TFS International Names Dr Suzanne Pavon As Executive Vice President, Quality Assurance 24
Apr 03, 2018: TFS International appoints Dr Andrew Copestake as Chief Commercial Officer 25
Jan 10, 2018: TFS International Appoints New Chief Executive Officer 26
Jul 13, 2017: TFS International Appoints Mr. Ryan Shortreed as Chief Financial Officer, Mr. Martin Filippides as Vice President Human Resources and Mr. Young Shon as Chief Information Officer 27
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
TFS International AB, Pharmaceuticals & Healthcare, Key Facts 2
TFS International AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TFS International AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TFS International AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TFS International AB, Deals By Therapy Area, 2012 to YTD 2018 8
TFS International AB, Medical Devices Deals, 2012 to YTD 2018 9
TFS International AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
TFS Trial Form Support International Completes Acquisition Of Contract Research Business Of Semcon Caran 11
Ratos to Acquire 60% Stake in TFS International 13
Araclon Biotech Enters into Agreement with TFS International 14
TiGenix Forms Partnership with TFS International 15
TFS Enters into Agreement with SCIderm for Dermatology Trials 16
TFS International Acquires SCIderm 17
TFS Trial Form Support International Acquires Beardsworth Consulting, Contract Research Organization 18
TFS Trial Form Support International Acquires Dimensione Ricerca, Clinical CRO 19
TFS International AB, Key Competitors 20
TFS International AB, Key Employees 21
TFS International AB, Subsidiaries 22

List of Figures
TFS International AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
TFS International AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
TFS International AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
TFS International AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
TFS International AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TFS International AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
TFS International AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TFS International AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
TFS International AB, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[TFS International AB:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Salk Institute for Biological Studies:製薬・医療:M&Aディール及び事業提携情報
    Summary Salk Institute for Biological Studies (Salk) is a research institute that offers biological research programs. The institute’s areas of research comprise aging and regenerative medicine, cancer biology, immune system biology, metabolism and diabetes, neuroscience and neurological disorders, …
  • Aptiv Plc
    Aptiv Plc - Strategy, SWOT and Corporate Finance Report Summary Aptiv Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Takara Holdings Inc.:企業の戦略・SWOT・財務情報
    Takara Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Takara Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Aurora Spine Corp (ASG):企業の製品パイプライン分析2018
    Summary Aurora Spine Corp (Aurora) is a medical equipment provider that offers surgical tools. The company offers novel solutions in the spinal implant market through a range of minimally invasive, and regenerative spinal implant technologies. It develops and distributes spinal implant products whic …
  • Datang International Power Generation Co Ltd (991):企業の財務・戦略的SWOT分析
    Datang International Power Generation Co Ltd (991) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Swan Life Ltd.:企業の戦略・SWOT・財務情報
    Swan Life Ltd. - Strategy, SWOT and Corporate Finance Report Summary Swan Life Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Spinal Elements Inc:医療機器:M&Aディール及び事業提携情報
    Summary Spinal Elements Inc (Spinal Elements), formerly Quantum Orthopedics Inc, a subsidiary of Spinal Elements, is a medical device manufacturing company that manufactures spinal implants and instruments. The company provides products such as cervical implant systems, anterior cervical plate syste …
  • Bangchak Corporation PCL (BCP):石油・ガス:M&Aディール及び事業提携情報
    Summary Bangchak Corporation PCL (Bangchak) is an integrated energy company. Its core business is petroleum refining, procuring crude oil from domestic and international sources and refining it into various petroleum products. The company’s major products include gasoline, gasohol, jet fuel, diesel, …
  • ProMetic Life Sciences Inc (PLI):企業の財務・戦略的SWOT分析
    ProMetic Life Sciences Inc (PLI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • CitiPower and Powercor:企業の戦略的SWOT分析
    CitiPower and Powercor - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Human Longevity Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Human Longevity Inc (HLI) is a genomics-based technology company that develops sequenced genomes and phenotypic database. The company’s discovery capabilities include streamlining drug development, rescuing and repurposing drugs from failed clinical trials and discovery of biomarker and comp …
  • Pyxant Labs Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Pyxant Labs Inc (Pyxant) is a bioanalytical laboratory that offers laboratory services. The laboratory’s services include picogram-level bioanalytical method development and validation, analytical and bioanalytical support for ADME studies, and analytical and bioanalytical support for pharma …
  • Intra Energy Corporation Ltd (IEC):電力:M&Aディール及び事業提携情報
    Summary Intra Energy Corporation Limited (IEC), formerly Atomic Resources Limited, is a mining and energy company that operates through subsidiaries, affiliates, and joint ventures. It explores and mines coal, mineral resources, ore reserves, and uranium through operating interests in various mines. …
  • Murmanskoye Morskoye Parokhodstvo:企業の戦略・SWOT・財務分析
    Murmanskoye Morskoye Parokhodstvo - Strategy, SWOT and Corporate Finance Report Summary Murmanskoye Morskoye Parokhodstvo - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Lepu Medical Technology (Beijing) Co Ltd (300003)-製薬・医療分野:企業M&A・提携分析
    Summary Lepu Medical Technology (Beijing) Co Ltd (Lepu Medical) is a medical device company that designs, develops, and distributes medical equipments. The company’s products include interventional cardiology products, cardiac in vitro diagnosis products, occlusion devices, pacemaker, angiographic e …
  • National Health Insurance Company – Daman PJSC:企業の戦略・SWOT・財務分析
    National Health Insurance Company – Daman PJSC - Strategy, SWOT and Corporate Finance Report Summary National Health Insurance Company – Daman PJSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Ujaas Energy Ltd (UJAAS):企業の財務・戦略的SWOT分析
    Summary Ujaas Energy Ltd (Ujaas) is a renewable energy company that offers solar energy development products and services. The company provides products such as home products, park products, transformers, and others. It offers transformers products such as power transformer, convertor transformers, …
  • BioDelivery Sciences International Inc (BDSI):企業の財務・戦略的SWOT分析
    BioDelivery Sciences International Inc (BDSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Enmax Corporation:発電所・企業SWOT分析
    Enmax Corporation – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • Nippon Sheet Glass Company Limited :企業の戦略・SWOT・財務情報
    Nippon Sheet Glass Company Limited - Strategy, SWOT and Corporate Finance Report Summary Nippon Sheet Glass Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆